171 related articles for article (PubMed ID: 6424310)
1. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
[No Abstract] [Full Text] [Related]
2. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
Maurin N
Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
[TBL] [Abstract][Full Text] [Related]
3. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
5. Response of human platelets to sheer stress.
Brown CH; Lemuth RF; Hellums JD; Leverett LB; Alfrey CP
Trans Am Soc Artif Intern Organs; 1975; 21():35-9. PubMed ID: 1146007
[No Abstract] [Full Text] [Related]
6. The biochemical mechanisms of shear-induced platelet aggregation.
Hardwick RA; Gritsman HN; Stromberg RR; Friedman LI
Trans Am Soc Artif Intern Organs; 1983; 29():448-53. PubMed ID: 6673266
[No Abstract] [Full Text] [Related]
7. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
Cowley AJ; Heptinstall S; Hampton JR
Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
10. [Kinetics of the cellular response: the phenomenon of supercooperativity in platelet aggregation].
Vrzheshch PV; Tatarintsev AV; Ershov DE; Fedorov NA; Zaĭtsev SV; Varfolomeev SD
Dokl Akad Nauk SSSR; 1989; 307(2):477-80. PubMed ID: 2509180
[No Abstract] [Full Text] [Related]
11. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
Briel RC; Lippert TH
Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
[TBL] [Abstract][Full Text] [Related]
12. Blood platelet behaviour in mothers and neonates.
Andrews NP; Broughton Pipkin F; Heptinstall S
Thromb Haemost; 1985 Jun; 53(3):428-32. PubMed ID: 3931289
[TBL] [Abstract][Full Text] [Related]
13. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
Viisoreanu D; Gear A
Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
[TBL] [Abstract][Full Text] [Related]
14. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
[No Abstract] [Full Text] [Related]
15. The role of phosphorylation/dephosphorylation reactions in the function of blood platelets.
Gerrard JM; Beattie LL; Israels SJ; Park J
Agents Actions Suppl; 1986; 20():129-45. PubMed ID: 3101441
[No Abstract] [Full Text] [Related]
16. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
Pataricza J; Bor P; Szekeres L
Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dog platelet reactivity following 1-benzylimidazole administration.
Harris RH; Fitzpatrick T; Schmeling J; Ryan R; Kot P; Ramwell PW
Adv Prostaglandin Thromboxane Res; 1980; 6():457-61. PubMed ID: 7386278
[No Abstract] [Full Text] [Related]
18. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
[No Abstract] [Full Text] [Related]
19. [Quantitative method of measuring platelet ATP released in vitro in the presence of various aggregating agents].
Jung G; Hénon P
Pathol Biol (Paris); 1984 Sep; 32(7):772-8. PubMed ID: 6436777
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
